Skip to main content
About
Policy Issues
Scientific Innovation
Patient Support
News
Resources
Blog
Sites
Innovation.org
MAT.org
PhRMA.org
Exit Search
Exit Search
About
Policy Issues
Scientific Innovation
Patient Support
News
Resources
Blog
Sites
Innovation.org
MAT.org
PhRMA.org
Search in PhRMA
Search
All
News
Resources
Blogs
Search
The Value Collaborative
Policy Portal
PhRMA
Share This
Reports
Applying ICER Assessments in Medicaid Could Limit Patients’ Access to Medicines
Report
REport
Milliman Study on Limitations in Using ICER’s “Potential Budget Impact” Work to Guide Private Payer Budget Decisions
Report
REport
Milliman Study on the Utility of ICER Reports for Private Payer Drug Coverage Decision-Making
Report
REport
How ICER’s Flawed Budget Impact Threshold Can Harm Patient Access
Report
REport
Using ICER’s Value Assessments Would Limit Access to Life-Saving Medicines in Medicare Part B
Report
REport
Delivering Results for Patients: The Value of Value-Based Contracts
Report
Report
Policy Solutions
READ MORE
Biopharmaceutical Company Communications with Health Care Stakeholders
Report
Report
Policy Solutions: Promoting Value-Driven Health Care
REPORT
Comment Letters
PhRMA Comment on the Health Care Innovation Caucus Request for Information
Speeches & Communication
Speeches & Communication
PhRMA Comments on CMS Proposed Rule on Changes to Medicaid
Speeches & Communication
read more
PhRMA Comment on OIG Regulatory Sprint Proposed Rule
Speeches & Communication
read more
PhRMA Comment: Call for Public Input on ICER Value Framework
Fact Sheet
Read More
PhRMA Comment Medical Product Communications That Are Consistent With the FDA Required Labeling Questions and Answers
Fact Sheet
Read More
Fact Sheets
Results-Based Contracting: The Need to Reconsider the Anti-Kickback Statute
Fact Sheet
fact sheet
How ICER’s Assessment of New Migraine Treatments Ignores Patient Needs
Fact Sheet
fact sheet
Biopharmaceutical Companies’ Personalized Medicine Research Yields Innovative Treatments for Patients
Fact Sheet
Read More
Codes & Guidelines
A Delicate Balance - Pharmaceutical Innovation and Access
Codes & Guidelines
Read More
Patient-Perspective Value Framework
Codes & Guidelines
Read More
PhRMA Positions on Quality and Performance Measurement
Codes & Guidelines
Read More
Principles for Value Assessment Frameworks
Codes & Guidelines
Codes & Guidelines
Responsible Sharing of Information About Medicines
Codes & Guidelines
Read More
PhRMA Policy Solutions_Delivering Innovative Treatments to Patients
Codes & Guidelines
Read More